NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.

Katharina T Prochazka; Thomas Melchardt; Florian Posch; Konstantin Schlick; Alexander Deutsch; Christine Beham-Schmid; Lukas Weiss; Thomas Gary; Daniel Neureiter; Eckhard Klieser; Richard Greil; Peter Neumeister; Alexander Egle; Martin Pichler

doi:10.1038/bjc.2016.325

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.

Katharina T Prochazka, Thomas Melchardt (Co-Autor/-in), Florian Posch, Konstantin Schlick (Co-Autor/-in), Alexander Deutsch, Christine Beham-Schmid, Lukas Weiss (Co-Autor/-in), Thomas Gary, Daniel Neureiter (Co-Autor/-in), Eckhard Klieser (Co-Autor/-in), Richard Greil (Co-Autor/-in), Peter Neumeister, Alexander Egle (Co-Autor/-in), Martin Pichler

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum
Universitätsinstitut für Pathologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

29 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	1264-1272
Fachzeitschrift	BRITISH JOURNAL OF CANCER
Jahrgang	115
Ausgabenummer	10
DOIs	https://doi.org/10.1038/bjc.2016.325
Publikationsstatus	Veröffentlicht - 2016

Zugriff auf Dokument

10.1038/bjc.2016.325

Dieses zitieren

Prochazka, K. T., Melchardt, T., Posch, F., Schlick, K., Deutsch, A., Beham-Schmid, C., Weiss, L., Gary, T., Neureiter, D., Klieser, E., Greil, R., Neumeister, P., Egle, A., & Pichler, M. (2016). NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. BRITISH JOURNAL OF CANCER , 115(10), 1264-1272. https://doi.org/10.1038/bjc.2016.325

Prochazka, Katharina T ; Melchardt, Thomas ; Posch, Florian et al. / NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. in: BRITISH JOURNAL OF CANCER 2016 ; Jahrgang 115, Nr. 10. S. 1264-1272.

@article{4515fe2458954d7aa259f4bccc34f226,

title = "NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.",

keywords = "FOLLOW-UP, MORTALITY, CANCER, DEATH, MODEL",

author = "Prochazka, {Katharina T} and Thomas Melchardt and Florian Posch and Konstantin Schlick and Alexander Deutsch and Christine Beham-Schmid and Lukas Weiss and Thomas Gary and Daniel Neureiter and Eckhard Klieser and Richard Greil and Peter Neumeister and Alexander Egle and Martin Pichler",

note = "Melchardt, Schlick, Weiss, Greil, Egle: Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University Salzburg, Salzburg 5020, Austria; Neureiter, Klieser:Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg 5020, Austria.",

year = "2016",

doi = "10.1038/bjc.2016.325",

language = "English",

volume = "115",

pages = "1264--1272",

journal = "BRITISH JOURNAL OF CANCER ",

issn = "0007-0920",

publisher = "Springer Nature",

number = "10",

}

Prochazka, KT, Melchardt, T, Posch, F, Schlick, K, Deutsch, A, Beham-Schmid, C, Weiss, L, Gary, T, Neureiter, D , Klieser, E , Greil, R, Neumeister, P, Egle, A & Pichler, M 2016, 'NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.', BRITISH JOURNAL OF CANCER , Jg. 115, Nr. 10, S. 1264-1272. https://doi.org/10.1038/bjc.2016.325

NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. / Prochazka, Katharina T; Melchardt, Thomas (Co-Autor/-in); Posch, Florian et al.
in: BRITISH JOURNAL OF CANCER , Jahrgang 115, Nr. 10, 2016, S. 1264-1272.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.

AU - Prochazka, Katharina T

AU - Melchardt, Thomas

AU - Posch, Florian

AU - Schlick, Konstantin

AU - Deutsch, Alexander

AU - Beham-Schmid, Christine

AU - Weiss, Lukas

AU - Gary, Thomas

AU - Neureiter, Daniel

AU - Klieser, Eckhard

AU - Greil, Richard

AU - Neumeister, Peter

AU - Egle, Alexander

AU - Pichler, Martin

N1 - Melchardt, Schlick, Weiss, Greil, Egle: Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University Salzburg, Salzburg 5020, Austria; Neureiter, Klieser:Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg 5020, Austria.

PY - 2016

Y1 - 2016

KW - FOLLOW-UP

KW - MORTALITY

KW - CANCER

KW - DEATH

KW - MODEL

U2 - 10.1038/bjc.2016.325

DO - 10.1038/bjc.2016.325

M3 - Original Article

C2 - 27764838

SN - 0007-0920

VL - 115

SP - 1264

EP - 1272

JO - BRITISH JOURNAL OF CANCER

JF - BRITISH JOURNAL OF CANCER

IS - 10

ER -

Prochazka KT, Melchardt T, Posch F, Schlick K, Deutsch A, Beham-Schmid C et al. NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. BRITISH JOURNAL OF CANCER . 2016;115(10):1264-1272. doi: 10.1038/bjc.2016.325